No, today's announcement just shows that Novo Nordisk have decided not to develop the product. That doesn't mean that another pharma won't.
(I speak as someone with a fair bit of money invested for quite some time. But my view is not wishful thinking, it's carefully considered. Nevertheless, IMHO, DYOR, etc.)
Add to My Watchlist
What is My Watchlist?